CONTENTS:
- Frequency and risk of marijuana use among substance-using health care patients in Colorado with and without access to state legalized medical marijuana. Richmond M.K., Pampel F.C., Rivera L.S., Broderick K.B., Reimann B., Fischer L., p. 1-9.
- Stigma among California's medical marijuana patients. Satterlund T.D., Lee J.P., Moore R.S., p. 10-17.
- Profiles of medicinal cannabis patients attending compassion centers in Rhode Island. Zaller N., Topletz A., Frater S., Yates G., Lally M., p. 18-23.
- Application of the passionate attachment model to recreational use of MDMA/Ecstasy. Davis A.K., Rosenberg H., p. 24-29.
- "Word of Mouse": Indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine. Van Hout M.C., Hearne E., p. 30-41.
- The prevalence of posttraumatic stress disorder symptoms among addiction treatment patients with cocaine use disorders. Saunders E.C., Lambert-Harris C., McGovern M.P., Meier A., Xie H.Y., p. 42-50.
- Substance use among a national sample of Asian/Pacific islander men who have sex with men in the U.S. Nehl E.J., Han J.H., Lin L., Nakayama K.K., Wu Y., Wong F.Y., p. 51-59.
- The relationship between the accumulated number of role transitions and hard drug use among Hispanic emerging adults. Allem J.-P., Soto D., Baezconde-Garbanati L., Unger J., p. 60-64.
- Alcohol screening among opioid agonist patients in a primary care clinic and an opioid treatment program. Klimas J., Muench J., Wiest K., Croff R., Rieckman T., McCarty D., p. 65-70.
- Women who inject drugs in the Republic of Georgia: In their own words. Kirtadze I., Otiashvili D., O'Grady K., Zule W., Krupitsky E., Wechsberg W., et al., p. 71-79.
- A critical component of the continuum of care for substance use disorders: Recovery homes in Philadelphia. Mericle A.A., Miles J., Cacciola J., p. 80-90.